As of May 23
| -0.04 / -1.35%|
The 1 analysts offering 12-month price forecasts for Neptune Technologies & Bioressources Inc have a median target of 4.10, with a high estimate of 4.10 and a low estimate of 4.10. The median estimate represents a +40.07% increase from the last price of 2.93.
The current consensus among 1 polled investment analysts is to Buy stock in Neptune Technologies & Bioressources Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.